| Factor Information | |
|---|---|
| Data ID | 3981 |
| Factor | Homocysteine (μmol/L), median (IQR) |
| Description | The prevalence of CHD in live births is 10.5‰ (131/12 402) based on the present available data |
| Biomarker | NA |
| Classification | E2 (physiological factor - biochemical index) |
| Association | |
|---|---|
| Application | prognosis |
| Objective | To investigate the associations of parental periconceptional nutritional factors with CHD. |
| Conclusion | 151 cases of CHD were identified after birth. The pilot analysis in a small subgroup showed that approximately 20.0% of preconception women and 44.9% of early-pregnancy women had red blood cell (RBC) folate levels that met the international recommendation for preventing neural tube defects. |
| Risk Factor | unknown |
| CHD Type | |
|---|---|
| ID | 148 |
| CHD Type | NA |
| CHD Subtype | NA |
| Reference | |
|---|---|
| PMID | 31767384 |
| Year | 2019 |
| Title | Risk of coronary artery disease in adults with congenital heart disease: A comparison with the general population |
| Sample | ||
|---|---|---|
| Population | adults | |
| Source | serum | |
| Region | Shanghai, China | |
| Method | using electrochemiluminescence assays (ARCHITECT i2000SR Analyzer; Abbott Laboratories, USA) | |
| Race | Asian | |
| Disease History | N/A | |
| Treatment History | N/A | |
| Group | preconception women(Treatment) | early pregnant women(Control) |
| Number | 624 | 599 |
| Age | 29.9±3.9 years | 29.9±4.0 years |
| Gender (Male: Female) | 0:624 | 0:599 |
| Marker Level | 6.5 (5.2–8.6)(μmol/L) | 4.2 (3.5–5.2)(μmol/L) |
